Jose Jimeno
Panama, Panama
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Insight and benefits from vaccine clinical trials with adaptive designs: a scoping review.
Journal: Translational and clinical pharmacology
Published: April 08, 2025
Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.
Journal: The Lancet. Infectious diseases
Published: July 04, 2023
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials.
Journal: The Journal of infectious diseases
Published: July 08, 2021
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Journal: Lancet (London, England)
Published: October 16, 2020
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.
Journal: The Lancet. Infectious diseases
Published: April 06, 2020
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Journal: Lancet (London, England)
Published: February 13, 2020
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
Journal: The New England journal of medicine
Published: November 07, 2019
Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: September 18, 2017
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
Journal: Lancet (London, England)
Published: May 24, 2016
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.
Journal: The Lancet. Infectious diseases
Published: September 21, 2015
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
Journal: The Lancet. Infectious diseases
Published: April 28, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026